Assessment of functional capacity through oxygen consumption in patients with asymptomatic probable heart disease

Original Article

Assessment of Functional Capacity through Oxygen Consumption in Patients with Asymptomatic Probable Heart Disease

Luiz Oswaldo Carneiro Rodrigues, Emerson Silami-Garcia, Maria da Consolação Vieira Moreira, Giane Amorim Ribeiro

Belo Horizonte, MG - Brazil

PURPOSE: To compare peak exercise oxygen consumption (VO_2peak) of healthy individuals with asymptomatic individuals with probable heart disease.

METHODS: Ninety-eight men were evaluated. They were divided into two groups: 1) 39 healthy individuals (group N) with an age range of 50±4.6 years; and 2) 59 asymptomatic individuals with signs of atherosclerotic and/or hypertensive heart disease (group C) with an age range of 51.9±10.4 years. In regard to age, height, body surface area, percentage of fat, lean body mass, and daily physical activity, both groups were statistically similar. Environmental conditions during the ergometric test were also controlled.

RESULTS: Maximal aerobic power (watts), VO_2peak, maximal heart rate, and maximal pulmonary ventilation were lower in group C (p<0.01) than in group N; weight, however, was lower in group N (p=0.031) than in group C. Differences in the respiratory gas exchange index, heart rate at rest, and the maximal double product of the two groups were not statistically significant.

CONCLUSION: Signs of probable heart disease, even though asymptomatic, may reduce the functional capacity, perhaps due to the lower maximal cardiac output and/or muscle metabolic changes.

Key words: functional capacity, oxygen consumption, heart disease

Maximal oxygen consumption (VO_2max) has been considered the best indicator of the human capacity for tolerating prolonged effort ¹. Its assessment, however, has some technical difficulties, especially in individuals with lower physical fitness or those limited by heart disease ². Therefore, the greatest oxygen consumption during exercise, called peak exercise oxygen consumption (VO_2peak), is considered an objective indicator of functional capacity. It may also provide an indirect and accurate assessment of cardiac reserve ³. VO_2peak is considered particularly reliable in functional assessment when associated with measurement of anaerobic metabolism⁴, either through measurement of blood lactate ^5,6 or through recording ventilatory variables ², in young and middle-aged individuals ⁷.

Several authors have shown a strong correlation between exercise capacity assessed through VO_2peak and the prognosis and severity of congestive heart failure (CHF): the one-year mortality rate is higher in patients with VO_2peak below 10 mL/kg.min; this group of patients can benefit from heart transplantation ^8,9. VO_2peak may also reveal changes in exercise capacity due to the use of medicines, reflecting, more precisely, the compensatory adjustments and the prognosis of the CHF than any other hemodynamic and clinical indicator ^2,10-14.

VO_2peak, therefore, has become an important prognostic tool in the evaluation and selection of candidates for cardiac transplantation. All patients with stable terminal CHF should have their functional capacity evaluated through the direct measurement of oxygen consumption, as part of the mandatory procedures for selection for cardiac transplantation ¹⁵. Most of the patients with VO_2peak higher than 14mL/kg.min^-1 can wait longer for transplantation even though VO_2peak is only one of the criteria to be considered in each patient ¹³.

Although VO_2peak provides an indicator for cardiac output (CO) and cardiac reserve, factors, such as age, sex, level of physical fitness, muscle mass, and angina, can influence its results ². For example, a VO_2peak of 14mL/kg.min^-1 accounts for approximately 60% of the maximal exercise capacity expected in an active 60-year-old man, but only 30% of the capacity of an active 20-year-old man; such a low exercise capacity would be an unacceptable quality of life for a young adult ¹⁶.

On the other hand, despite the recognized usefulness of the VO_2peak in measuring symptomatic heart diseases, its value in asymptomatic or poorly symptomatic (NYHA class I) heart diseases is still being discussed ¹⁷. This study aimed to approach this question through a comparison of healthy individuals with asymptomatic individuals with signs of atherosclerotic and/or hypertensive heart disease.

Methods

This study was approved by the Ethics Committee of the Hospital das Clínicas of the Federal University of Minas Gerais (UFMG). The sample comprised 98 male volunteers, who signed a consent form, agreeing with the methodology of the study. They were divided into two groups: one with 39 healthy individuals (group N) and the other with 59 asymptomatic individuals with indicative (57.6%) or suggestive (43.2%) electrocardiographic signs of heart disease (group C). The indicative electrocardiographic signs of heart disease were the following: depression of the ST segment >2mm, during effort; complete bundle-branch block; left ventricular overload; and frequent ventricular extrasystoles triggered by effort. The electrocardiographic signs suggesting heart disease were the following: straightening and depression of the ST segment >1mm and <2mm, during effort; unspecific disorders of intraventricular conduction; unspecific alterations of repolarization; arrhythmias, such as nonsustained paroxysmal supraventricular tachycardia and isolated ventricular extrasystoles. In addition, group C also showed evidence of heart disease on coronary angiography (13.5%) and/or echocardiogram (11.8%). Group C, as a whole, comprised individuals with probable atherosclerotic and/or hypertensive heart disease; there was no suspicion of Chagas' cardiomyopathy, valvar disease nor any other disease.

Both groups underwent direct assessment of the VO_2peak through the direct method of spirometry with the use of an Ergopneumotest metabolimeter. Indirect determination of the anaerobic metabolism was also performed, as well as the determination of other metabolic, cardiovascular and ventilatory variables during standard exercise until exhaustion ¹², in a electronically braked bicycle ergometer (Monark), at a speed of 18 km/h. All patients underwent an ergometric test until exhaustion, characterized as the moment at which the predetermined potency and/or velocity could no longer be maintained. The examiners did not interrupt the tests. The maximal aerobic power (POW) was equivalent to the highest value observed during at least 3 minutes of exercise and VO_2peak was obtained during this period. Exercise was subjectively evaluated through the rating of perceived exertion (REP) (from 0 to 10) scale ¹⁸. Electrocardiogram (ECG) and heart rate (HR) were continuously monitored during rest and exercise until exhaustion and also for 10 minutes during recovery. Blood pressure (BP) was obtained through a sphygmomanometer graduated in mmHg. Bicycle ergometetric tests were performed in an environment with air conditioning to maintain temperature (between 21 and 24°C) and relative humidity (between 50 and 75%) levels so that heat stress was unlikely ¹⁹. The impact of heat stress was calculated through the wet bulb globe temperature index (WBGTI) ^20,21. Tests comparing the mean of variables with normal distribution were performed, as well as nonparametric tests, when necessary, adopting the significance level of p<0.05.

Results

Table I shows that groups N and C were similar in regard to the following variables: age, usual physical activity, HR at rest, maximal cardiac work, ventilatory equivalent for oxygen, BP variation during exercise, respiratory gas exchange index, REP at the potency of 100 watt, dry environmental temperature, humid environmental temperature, relative humidity of the air.

Table I

Table II shows that, when group C was subdivided in regard to the presence or absence of hypertension and use of medication there were no differences in the peak exercise oxygen consumption and oxygen pulse. In the subgroup of hypertensive patients, however, the use of medication reduced the maximal aerobic power and maximal HR.

Discussion

The measure of VO_2peak in healthy individuals in this study showed results consistent with those obtained in previous studies ²² in regard to the age of the volunteers ^2,16,23.

The lower VO_2peak in group C, when compared with that of healthy individuals in the same age range, suggests that the presence of signs of heart disease, even though the patient is asymptomatic, can reduce functional capacity ²⁴. In the present study, this decrease was 2 METs, representing a significant reduction in the physical capacity for work, leisure and daily activities, corresponding to 14 to 16 years of early aging¹⁶. A decrease of 3 METs was also observed in a group of individuals with Chagas' heart disease, when compared with healthy individuals in the same age range ¹⁷.

Findings of the present study also suggest that both the direct measure of oxygen consumption (VO_2peak, in mL/kg.min^-1) and the measure of the maximal aerobic power (POW, in watt/kg) can identify the reduction in functional capacity, even for those asymptomatic individuals with signs of heart disease (Table I). POW, however, was statistically 10 times more sensitive than VO_2peak for detecting a reduction in the functional capacity of group C participants, when compared with the healthy individuals. In addition, POW revealed some significant differences due to hypertension and use of medication in group C, which did not occur with VO_2peak (Table II). These findings are not in accordance with that which has been postulated for the diagnosis of the functional capacity in patients with heart disease ²⁵ and also for the prescription of exercise ⁷. However, the highest sensitivity of POW in the assessment of the functional capacity has also been observed for women ²⁶.

Some mechanisms may be involved in the decrease of the functional capacity in group C, for example a reduction in the maximal CO (Q_max) due to the probable heart disease, hypertension or the use of medication; muscle metabolic alterations; and the iatrogenic sedentary lifestyle caused by the diagnosis.

At the beginning, the simple presence of signs of heart disease as a criterion of inclusion in group C could suggest that the limiting factor in the functional capacity would be a reduction in Q_max. Even though this study did not assess Q_max directly, the maximal cardiac work of group C (Table I) was similar to that of the healthy group, and this similarity of the maximal double product (DP_max) occurred due to a lower HR_max in group C, resulting from a higher BP in this group. This implies that when the same maximal cardiac work is reached with a lower HR, there is a smaller Q_max in group C, even though the stroke volume is kept constant ²⁷.

When group C, however, is subdivided into normotensive and hypertensive individuals (Table II), one observes that peak exercise oxygen consumption (VO_2peak) and oxygen transportation per cardiac beat (P_oxy) are not different in the two groups, indicating that the presence of hypertension is not the main cause of the lower capacity of oxygen uptake and transportation among individuals in group C. Hypertension, however, caused a reduction in POW in this group, suggesting the existence of a peripheral reducing factor.

Observation of P_oxy shows that less oxygen was consumed and/or less blood was transported per cardiac beat in group C (Table I), which could result from the lower stroke volume or from the smaller peripheral extraction of oxygen. It is known that chronic heart failure renders the skeletal muscle function difficult, independently from blood flow and from the availability of oxygen ^28,29. It is also known that individuals with symptomatic heart diseases can have metabolic dysfunctions of the skeletal muscles, which reduce their functional capacity ³⁰. Observation of the respiratory gas exchange index and of the ventilatory equivalent for oxygen (V_E/VO₂) shows that group C reached the same relative level of lactic metabolic acidosis, but with absolute lower efforts than healthy individuals. This finding indicates the precocious predominance of the anaerobic glycolysis, strengthening the hypothesis that the best functional capacity can result either from the lowest blood supply to the muscles (smaller stroke volume) or from the smallest peripheral extraction of oxygen (muscle metabolic dysfunction) in group C.

The use of some medicines, especially those blockers of the sympathetic activity upon the heart, may decrease the capacity of adequately adjusting CO during exercise, reducing the blood supply to tissue, resulting in a smaller physical capacity in group C. In this group, 57% of the patients used medicines that were potential cardiac capacity reducing agents, resulting in some degree of chronotropic block and reduction in the maximal power in the hypertensive patients during exercise. There were, however, no significant differences in regard to VO_2peak and no significant repercussion on the response of BP during exercise (Table II). These data do not support the hypothesis that group C would have a smaller Q_max due to the use of medicines, even though the drugs caused a reduction in maximal power.

Lack of physical fitness is one of the most important factors in the reduction of functional capacity at any age ²³. Medical and/or cultural factors could contribute to resistance of patients to becoming involved in physical activities more effective in promoting fitness. In the present study, group C had an usual mean physical activity similar to that of healthy individuals (Table I), i.e., they do not have a more sedentary lifestyle than healthy individuals, not justifying the smallest functional capacity observed in group C. The coefficient of variation of usual physical activity in this study, however, was very high, indicating the need for further studies.

The REP, measured in the power of 100 watt and reached by all the individuals, was not statistically different between the two groups N and C, showing that the REP scale was not sensitive to the reduction in the functional capacity. Perhaps this may occur because the individuals in group C were still at a higher functional level than that described as a threshold (18 mL/kg.min^-1) for the subjective perception of their own dysfunction ³¹.

Finally, the room temperature during the tests was slightly cold ¹⁹. In such an environment, possible cardiovascular overload resulting from heat stress was statistically higher than that of environmental conditions in which the healthy individuals underwent ergometric tests. This would not explain, however, the reduction in the functional capacity observed in group C. Nevertheless, the magnitude of the increase observed in the WBGTI between the two environments does not seem to cause significant variations in performance during physical activity ³¹.

In conclusion, the lower VO_2peak and POW found in group C indicate that signs of heart disease, even though asymptomatic, can significantly decrease functional capacity. The measure of POW seems to be more sensitive than that of VO_2peak for detecting a reduction in functional capacity caused by the asymptomatic probable heart disease. The mechanisms of this decrease have not yet been well clarified and reduction in the maximal CO and/or peripheral metabolic changes are suggested as hypotheses.

Universidade Federal de Minas Gerais – UFMG

Mailing address: Luiz Oswaldo Carneiro Rodrigues - Laboratório de Fisiologia do Exercício – Campus da Pampulha – UFMG - Av. Presidente Carlos Luz, 4664 – 31310-250 - Belo Horizonte – MG - Brazil

• 1. Sutton JR. VO_2max New concepts on an old theme. Med Sci Sport Exerc 1992; 24: 26-9.
• 2. Itoh, H, Taniguchi K, Koike A, Doi M. Evaluation of severity of heart failure using ventilatory gas analysis. Circulation 1990; 81(suppl II): 31-7.
• 3. Wilson JR, Mancini DM. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993a; 22(suppl A): 93-8.
• 4. Romano A, Silva PRS, Ramirez JAF, Mady C, Yasbek Jr P. Exercício físico na insuficięncia cardíaca crônica estável. In: Yasbek P, Battistella LR. Do Atleta ao Transplantado. Condicionamento Físico. Săo Paulo: Sarvier 1994: 191-211.
• 5. Jennings GL, Esler MD. Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure. Circulation 1990; 81(suppl II): 5-13.
• 6. Consenso Nacional de Ergometria. Arq Bras Cardiol 1995; 65: 191-211.
• 7. Rondon MAPB, Forjaz CLM, Nunes N, Amaral SL, Barreto ACP, Negrăo CE. Comparaçăo entre a prescriçăo de intensidade de treinamento físico baseada na avaliaçăo ergométrica convencional e na ergoespirometria. Arq Bras Cardiol 1998; 70: 159-66.
• 8. Mancini DM, Eisen H, Kussmaul W, Mulkl R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
• 9. Cohn JN, Johson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrythmias and plasma norepinefrine as determinant of prognosis in heart failure. Circulation 1993; 87(suppl VI): 5-16.
• 10. Weber KT, Janicki JS. Respiratory gas exchange during exercise in the noninvasive evaluation of the severity chronic cardiac failure. In: Weber KT, Janicki JS, (eds). Cardiopulmonary Exercise Testing: Physiologic Principles and Clinical Applications. Philadelphia: WB Saunders, 1986: 221-35.
• 11. Mady C, Cardoso RHA, Barretto ACP, Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' Cardiomyopathy. Circulation 1994; 90: 3098-102.
• 12. Smith RF, Johnson, G, Ziesche S, Bath G, Blankenship K, Cohn JN. Functional capacity in heart failure. Comparison of methods for assessment and their relation to other index of heart failure. Circulation 1993; 87(suppl VI): 88-93.
• 13. Moreira MCV, Figueroa CCS. Transplante cardíaco. In: Pereira AW. Transplantes de Órgăos e Tecidos. Rio de Janeiro: Medsi, 1995: 235-59.
• 14. DeGroote P, Millaire A, Decoulx E, Nugue O, Guimier P, Ducloux G. Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy. J Am Coll Cardiol 1996; 28: 168-75.
• 15. Bethesda Conference. Guideline for heart transplantation. J Am Coll Cardiol 1993; 22: 21-30.
• 16. Stamford BA. Exercise and the elderly. Exerc Sport Sci Rev 1988; 16: 341-79.
• 17. Mady C, Cardoso RHA, Ianni BM, et al. Capacidade funcional máxima "normal" em pacientes com insuficięncia cardíaca congestiva por miocardiopatia chagásica. Arq Bras Cardiol 1996; 67: 1-4.
• 18. Borg G, Hassmen P, Lagstroem M. Perceived exertion related to heart rate and blood lactate during arm and leg exercise. Eur J Appl Physiol Occup Ther 1987; 56: 679-85.
• 19. Haymes EM, Wells LL. Environment and Human Performance. Illinois: Champaign Human Kinectics Publishers, 1986: 120-5.
• 20. Khogali M. Heat illness alert program - practical implications for management and prevention. Ann New York Academy of Sciences 1997: 526-31.
• 21. McCann DJ, Adams WC. Wet bulb globe temperature index and performance in competitive runners. Med Sci Sports Exerc 1997; 29: 955-61.
• 22. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Ver Resp Dis 1984; 129(suppl): s49-s55.
• 23. Kenney WL. Thermoregulation at rest and during exercise in healthy older adults. Exerc Sports Sci Ver 1997; 25: 41-76.
• 24. Mady C, Barreto ACP, Nacruth R, Mesquita ET, Bellotti G, Pileggi F. Maximal functional capacity in patients with cardiomyopathy due to Chagas' disease without congestive heart failure. J Am Coll Cardiol 1993; 21: 103A.
• 25. Young DR, Steinhardt MA. The importance of physical fitness for the reduction of coronary artery disease risk factors. Sports Med 1995; 19: 303:10.
• 26. Bishop D, Jenkins DG, Mackinnon LT. The relationship between plasma lactate parameters, W_peak and 1-h cycling performance in women. Med Sci Sports Exerc 1998; 30: 1270-5.
• 27. Semigran MJ, Thaik CM, Fifer MA, Boucher CA, Palacios IF, William GD - Exercise capacity and systolic and diastolic ventricular function after recovery from acute dilated cardiomyopathy. J Am Coll Cardiol 1994; 24: 462-70.
• 28. Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledingham J. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 1988; 78: 320-6.
• 29. Xu L, Poole DC, Musch TI. Effect of heart failure on muscle capillary geometry: implications for O₂ exchange. Med Sci Sports Exerc 1998; 30: 1230-7.
• 30. Wilson JR, Mancini DM. Skeletal muscle metabolic dysfunction. Implications for exercise intolerance in heart failure. Circulation 1993b; 87(suppl VII): 104-9.
• 31. Morey MC, Pieper CF, Cornoni-Huntley J. Is there a threshold between peak oxygen uptake and self-reported physical functioning in older adults? Med Sci Sports Exerc 1998; 30: 1223-9.

Publication Dates

• Publication in this collection
  24 Oct 2000
• Date of issue
  July 1999